Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Prediction of Amyloid-β pathology in amnestic mild cognitive impairment with neuropsychological tests

Date

Authors

Bahar-Fuchs, Alex

Villemagne, Victor

Ong, Kevin

Chetelat, Gael

Lamb, Fiona

Reininger, Cornelia B

Woodward, Michael

Rowe, Christopher

Publisher

IOS Press

Abstract

Assessment of disease biomarkers, particularly the in vivo assessment of amyloid-β (Aβ) burden with positron emission tomography (PET), is gradually becoming central to the diagnosis of mild cognitive impairment (MCI) due to Alzheimer's disease (AD). Ho

Keywords

Keywords: amyloid beta protein; florbetaben; adult; aged; Alzheimer disease; amnesia; article; clinical article; cognition; educational status; episodic memory; female; groups by age; hippocampus; human; male; mild cognitive impairment; neuropsychological test; nuc 18F Florbetaben PET; Aging; Alzheimer's disease; amyloid imaging; memory; mild cognitive impairment

URI

http://hdl.handle.net/1885/39324

Collections

ANU Research Publications

Source

Journal of Alzheimer's Disease

Type

Journal article

DOI

10.3233/JAD-2012-121315

Restricted until

2037-12-31

Downloads

File

Description

01_Bahar-Fuchs_Prediction_of_Amyloid-β_2013.pdf (303.16 KB)